Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 October 2019 | Story Ruan Bruwer | Photo Getty Images
Jaco Peyper
Jaco Peyper, former Kovsie, will handle a quarter-final match at the Rugby World Cup. It will also be his 50th test match.

With the appointment of Jaco Peyper as referee there will be Kovsie alumni among the referees, players and coaches in the quarter-finals of the 2019 Rugby World Cup in Japan on 20 October.

Lappies Labuschagné will start on the flank for Japan in their clash against the Springboks on Sunday. Labuschagné, a former Shimla captain, is second on the list for tackles made in the tournament thus far.
In the Springbok camp there are former University of the Free State (UFS) students in Rassie Erasmus (head coach) and Jacques Nienaber (defence coach).

UFS alumnus Jaco Peyper has been entrusted with the whistle in Sunday’s other quarter-final between Wales and France. It will be a memorable match for Peyper as it will be his 50th test appearance as the 31st man on the field – making him only the third South African to achieve this feat.

Peyper, who is the only South African among the 12 referees at the tournament, made his World Cup debut in 2015 when he officiated the opening match. In total he has handled six World Cup encounters. 

His illustrious career has seen him become only the fourth referee in history to officiate in 100 Super Rugby matches earlier in the year, in which he also handled the final (his fourth Super Rugby final). Peyper scooped the SA Referee of the Year award in 2018 for a third time, a year in which he took charge of his fourth Currie Cup Final.

“The fact that he is only the third South African referee to take charge of 50 tests indicates what a special achievement this is. It takes years of hard work and dedication to reach this level as a referee, and to maintain this standard year-in and year-out is even more challenging as it requires one to produce effective performances consistently,” said Jurie Roux, the CEO of SA Rugby.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept